Rochester, Minn.-based Mayo Clinic's innovation commercialization arm participated in a $60 million funding round for Nference, an artificial intelligence software startup, according to a Jan. 8 news release.
Nference's biomedical knowledge synthesis platform uses AI to compile vast amounts of healthcare data, making the information more accessible for the research, development and operational processes of the company's biopharmaceutical partners.
"Our strategic investment in Nference is a reflection of our confidence that a holistic knowledge synthesis platform that puts patient privacy first is the solution for effectively leveraging real-world evidence to spur innovation to benefit patient care," Andrew Danielsen, chair of Mayo Clinic Ventures, said in the release.
More articles on AI:
Merck innovation fund joins Cigna, Celgene in $28M precision medicine AI funding
Michigan Medicine AI boosts accuracy, precision of brain tumor diagnosis
Banner Health integrates AI-powered digital triage tool to improve patient experience